These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27456107)

  • 21. [Women and cardiovascular diseases].
    Sannito N; Lovreglio V
    Minerva Cardioangiol; 2002 Apr; 50(2):107-16. PubMed ID: 12032464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and stroke.
    Billeci AM; Paciaroni M; Caso V; Agnelli G
    Curr Vasc Pharmacol; 2008 Apr; 6(2):112-23. PubMed ID: 18393913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease is preventable among women.
    Kuller LH
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):175-87. PubMed ID: 20136604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and cardioprotection: the end of the tale?
    Rosano GM; Vitale C; Silvestri A; Fini M
    Ann N Y Acad Sci; 2003 Nov; 997():351-7. PubMed ID: 14644842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projected age- and sex-specific prevalence of cardiovascular diseases in Western Australian adults from 2005-2045.
    Sarink D; Nedkoff L; Briffa T; Shaw JE; Magliano DJ; Stevenson C; Mannan H; Knuiman M; Peeters A
    Eur J Prev Cardiol; 2016 Jan; 23(1):23-32. PubMed ID: 25305272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women.
    Kannel WB
    J Gend Specif Med; 2002; 5(2):27-37. PubMed ID: 11974672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
    Zárate A; Saucedo R; Basurto L; Martínez C
    Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women.
    Zhao D; Guallar E; Ouyang P; Subramanya V; Vaidya D; Ndumele CE; Lima JA; Allison MA; Shah SJ; Bertoni AG; Budoff MJ; Post WS; Michos ED
    J Am Coll Cardiol; 2018 Jun; 71(22):2555-2566. PubMed ID: 29852978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular risks differences in women: how can we improve the management?].
    Mounier-Vehier C; Delsart P; Letombe B
    Presse Med; 2010 Feb; 39(2):234-41. PubMed ID: 20074904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women.
    Gorodeski GI
    Exp Gerontol; 1994; 29(3-4):357-75. PubMed ID: 7925756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps.
    Aggarwal NR; Patel HN; Mehta LS; Sanghani RM; Lundberg GP; Lewis SJ; Mendelson MA; Wood MJ; Volgman AS; Mieres JH
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e004437. PubMed ID: 29449443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.
    Harvey RE; Coffman KE; Miller VM
    Womens Health (Lond); 2015 Mar; 11(2):239-257. PubMed ID: 25776297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and lifetime risk of coronary heart disease.
    Turin TC; Okamura T; Rumana N; Afzal AR; Watanabe M; Higashiyama A; Nakao YM; Nakai M; Takegami M; Nishimura K; Kokubo Y; Okayama A; Miyamoto Y
    Prim Care Diabetes; 2017 Oct; 11(5):461-466. PubMed ID: 28545843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease after menopause: a growing epidemic.
    Alexander J; Clearfield M
    Minerva Ginecol; 2006 Feb; 58(1):35-40. PubMed ID: 16498369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions.
    Godsland IF; Wynn V; Crook D; Miller NE
    Am Heart J; 1987 Dec; 114(6):1467-503. PubMed ID: 3318361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.
    Nair GV; Chaput LA; Vittinghoff E; Herrington DM;
    Chest; 2005 May; 127(5):1498-506. PubMed ID: 15888820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.